Opioid Addiction Treatment and Recovery: More Than Stability
Treatment can save a life long before treatment is finished.
This distinction is especially important in substance use treatment. A person may stop using illicit drugs, rebuild relationships, return to work, find stable housing, and become physically and emotionally healthier while receiving medication for opioid use disorder. These are substantial achievements and should never be minimized.
At the same time, being stable on treatment and being able to remain stable without treatment are not necessarily the same outcome.
At Astral Health, we believe both ideas can be true.
Treatment is not failure
Medication for opioid use disorder can be lifesaving. Buprenorphine can reduce illicit opioid use, cravings and withdrawal symptoms and substantially reduce the risks associated with untreated opioid use disorder.
Astral Health plans to offer office-based buprenorphine treatment for appropriate adult patients with opioid use disorder. We do not provide methadone treatment for opioid use disorder. Patients who need or prefer methadone treatment should receive care through an appropriate opioid treatment program.
There is no predetermined amount of time that every patient should remain on buprenorphine. Some patients may benefit from long-term treatment, while others may eventually want to explore whether they can remain stable without it.
The important question is not simply, "How long have you been taking this medication?"
It is also, "What is this medication doing for you now?"
Stability should lead to reassessment, not automatic continuation
When a patient transfers psychiatric care, Astral Health does not assume that every existing medication must be stopped. We also do not assume that every existing medication should automatically be continued indefinitely.
A medication that was appropriate several years ago may still be beneficial today. It may also be producing side effects, physical dependence, interactions, inconvenience, financial burden, or other problems that deserve reconsideration.
This applies to buprenorphine as well as medications used for anxiety, sleep, attention problems, depression, and other psychiatric conditions.
Our approach is to reassess:
What diagnosis is being treated?
Does the diagnosis still fit the patient's current presentation and history?
What benefit is the medication providing?
What happens when doses are missed or reduced?
Is there physical dependence?
Are there adverse effects or important interactions?
How is the patient functioning?
What has changed in the patient's life since treatment began?
Are there safer or simpler alternatives?
What are the patient's long-term goals?
Sometimes reassessment supports continuing the existing treatment. Sometimes it supports changing it. Sometimes the safest conclusion is that this is not the right time to make any change.
Medication-free stability can be a meaningful goal
Modern addiction medicine often uses the word "recovery" broadly. A person receiving buprenorphine may appropriately be described as being in recovery when compulsive illicit opioid use has stopped and health and functioning have substantially improved.
There is also another outcome worth recognizing.
Some people eventually reach a point where they are able to live well without illicit opioids, without medication for opioid use disorder, and without ongoing addiction treatment.
That outcome is not required of every patient, and it should never be forced simply to satisfy an abstract idea of what recovery is supposed to look like. However, it should not be dismissed either.
For a patient who has developed stable housing, supportive relationships, meaningful activities, employment or other responsibilities, effective coping skills, and substantial distance from the circumstances surrounding previous drug use, medication-free stability may become a reasonable long-term goal to discuss.
Reaching that point can represent an additional stage of progress.
Wanting to stop is not enough, and neither is wanting to continue
Substance use treatment involves an unusual difficulty: a patient's desire for or fear of losing a medication may itself require exploration.
"I want to stay on it" is important information, but it is not the entire clinical assessment.
Neither is "I want to get off everything."
A thoughtful treatment plan examines why the patient feels that way.
Is the patient experiencing continued benefit? Fear of withdrawal? Active craving? Previous unsuccessful attempts to discontinue treatment? Side effects? Stigma? Cost? A desire to feel independent of medication? Concern about relapse? Pressure from family?
Those answers matter.
The goal is not to force patients toward medication or away from medication. It is to understand what the medication is accomplishing and whether its current benefits continue to outweigh its risks and burdens.
Discontinuation is a clinical process
Buprenorphine should not be abruptly discontinued simply because a patient has been stable for a long time.
Physical dependence can develop during appropriate treatment. Withdrawal can be difficult, and return to illicit opioid use after discontinuation can carry serious overdose risk because opioid tolerance may be reduced.
When discontinuation is appropriate, it should be planned, gradual, monitored, and supported. A patient should also have a clear plan for what to do if cravings, psychiatric symptoms, or substance use return.
Needing that support does not mean a patient has failed.
It means treatment is being changed carefully.
Our Philosophy on Opioid Addiction Treatment and Recovery
At Astral Health, we believe opioid addiction treatment and recovery should remain purposeful and individualized.
We do not believe that a medication should continue indefinitely only because it was prescribed in the past. We also do not believe that stopping medication is automatically evidence of better treatment.
Our goal is to help each patient reach the highest level of health, stability, autonomy, and functioning that is realistically and safely available to them.
For some patients, that may include long-term medication.
For others, successful treatment may eventually include needing less medication or no longer needing a particular medication at all.
Both possibilities deserve to remain open.
When establishing care with Astral Health, existing diagnoses and medications are reviewed rather than automatically accepted or rejected. Treatment decisions are individualized based on history, current symptoms, functioning, risks, benefits, available evidence, and the patient's goals.
Progress matters.
So does continuing to ask whether there is another step forward.





Comments